MEI Pharma
MEIP
MEIP
53 hedge funds and large institutions have $23.2M invested in MEI Pharma in 2017 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+8
Holders Change %
+17.78%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
12
Reduced
16
Closed
11
Calls
$1.34M
Puts
$78K
Net Calls
+$1.27M
Net Calls Change
+$1.24M
Top Buyers
Top Sellers
| 1 |
IVM
InterWest Venture Management
San Francisco,
California
|
-$1.39M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$787K |
| 3 |
Goldman Sachs
New York
|
-$161K |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$142K |
| 5 |
Millennium Management
New York
|
-$92.3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CG
51
Cutler Group
San Francisco,
California
| $6K | – | – | – |
|
|
QI
52
QS Investors
New York
| $6K | +$6K | +118 | New |
|
|
RA
53
Royce & Associates
New York
| $4K | +$4K | +71 | New |
|
|
IVM
54
InterWest Venture Management
San Francisco,
California
| – | -$1.39M | -29,020 | Closed |
|
|
55
Fidelity Investments
Boston,
Massachusetts
| – | -$787K | -16,458 | Closed |
|
|
TC
56
TFS Capital
West Chester,
Pennsylvania
| – | -$194K | -4,057 | Closed |
|
|
57
Goldman Sachs
New York
| – | -$161K | -3,360 | Closed |
|
|
EGA
58
Eagle Global Advisors
Houston,
Texas
| – | -$82K | -1,708 | Closed |
|
59
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$46K | -962 | Closed |
|
|
HIM
60
Hillsdale Investment Management
Toronto,
Ontario, Canada
| – | -$44K | -925 | Closed |
|
|
BFM
61
Boothbay Fund Management
New York
| – | -$29K | -607 | Closed |
|
|
AIM
62
Acrospire Investment Management
Chicago,
Illinois
| – | -$27K | -572 | Closed |
|
63
Creative Planning
Overland Park,
Kansas
| – | -$3K | -57 | Closed |
|